Both in Biotechnology
Silexion Therapeutics vs Tessera Defense and Homeland Security
Over the past year SLXN returned −57.1% and HLSQ returned −86.1%; their daily moves had a correlation of 0.25.
SLXN −57.1% HLSQ −86.1%Growth of $1, one year, split-adjusted
| Metric | SLXN | HLSQ |
|---|---|---|
| Price | $0.1532 | $0.1770 |
| Market cap | $2.2M | $3.7M |
| Today | −7.54% | −14.62% |
| 1 month | −51.9% | −59.2% |
| 6 months | −97.6% | — |
| Year to date | −99.2% | — |
| 1 year | −99.6% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | — |
| Dividend yield | — | — |
| Volatility (60d) | 240.6% | — |
| Short % of float | 3.5% | 3.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).